INTER Krankenversicherung

INTER Krankenversicherung

INTER Krankenversicherung is a German health insurer headquartered in Mannheim. The firm operates as a regulated insurance carrier — a legal form that dictates its investment program serves policyholder reserves, not third-party discretionary capital. This structural anchor places the firm in the cohort of European insurers using general-account assets to build long-duration private-markets exposure. Allocable assets are directed almost exclusively into private-equity secondaries. The firm participates in LP-stake purchases, GP-led restructurings, and fund-portfolio acquisitions — the classic toolkit of a patient secondaries buyer. Unlike fund-of-funds assemblers or discretionary secondaries managers raising blind pools, INTER Krankenversicherung commits from its own balance sheet, which removes fundraising-cycle pressure and allows the team to hold positions across downturns. Representative transaction types include acquiring tail-end LP interests in European buyout funds, providing stapled primary commitments alongside strip-sale purchases, and backing continuation-vehicle solutions where GPs seek to extend hold periods on trophy assets. The firm operates from a single office in Mannheim. INTER Krankenversicherung has not publicly disclosed a dedicated alternatives investment headcount, nor has it marketed its secondaries program through placement agents or investor-relations roadshows. This deliberate absence of commercial signaling is typical of German insurer balance-sheet programs: the deployment strategy exists to fulfill actuarial liability-matching needs rather than to attract co-investor capital. No philanthropic structures or adjacent investment vehicles have been publicly identified. INTER Krankenversicherung represents the pure balance-sheet secondaries model: direct insurance-company capital deployed into private-markets illiquidity without intermediary fund layers. The absence of an alternatives team permanently fundraising for a commingled vehicle distinguishes the firm from the GP-led secondaries houses that dominate industry league tables. Succession and governance are dictated by the German insurance regulatory framework (BaFin), which imposes solvency-capital constraints that shape pacing and concentration limits — making the program structurally more conservative and perpetually-oriented than sponsor-backed secondaries platforms.